Steve Rowley

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma

Joonil Jung, Joon Sang Lee, Mark A. Dickson et al. · Nature Communications · 2016 · 94 citations · Full text

Medicine, Oncology, Pharmacology +16

A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization

Clare Pacini, Emma L. Duncan, Emanuel Gonçalves et al. · Cancer Cell · 2024 · 91 citations · Full text

Life Sciences, Genetics, Oncology +17

The resilience audit and the psychological contract

Patricia Hind, Max Frost, Steve Rowley · Journal of Managerial Psychology · 1996 · 70 citations

Management, Organization Studies, Organizational Behavior +16

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers

Aaron N. Hata, Steve Rowley, Hannah L. Archibald et al. · Oncogene · 2017 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +16

Relationship between Quantitative <i>GRB7</i> RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs et al. · Clinical Cancer Research · 2011 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +16